(Q33550523)

28 July 2017

The I-neb Adaptive Aerosol Delivery System enhances delivery of alpha1-antitrypsin with controlled inhalation (English)

1 reference

28 July 2017

David E Geller

1

1 reference

PubMed ID

20373910

28 July 2017

Kenneth C Kesser

series ordinal

2

1 reference

PubMed ID

20373910

28 July 2017

language of work or name

1 reference

1 April 2010

1 reference

Journal of Aerosol Medicine and Pulmonary Drug Delivery

28 July 2017

1 reference

28 July 2017

23 Suppl 1

1 reference

28 July 2017

S55-9

1 reference

Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of (99m)Tc-DTPA

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

High treatment burden in adults with cystic fibrosis: challenges to disease self-management

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Inhibition of airway proteases in cystic fibrosis lung disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Inflammation and anti-inflammatory therapies for cystic fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Lung deposition of inhaled alpha1-proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Lung deposition after electronically breath-controlled inhalation and manually triggered conventional inhalation in cystic fibrosis patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Controlled inhalation of aerosolised therapeutics.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Optimum peripheral drug deposition in patients with cystic fibrosis.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Peripheral deposition of alpha1-protease inhibitor using commercial inhalation devices

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3116627

Aerosol α1 -antitrypsin treatment for cystic fibrosis

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20373910

12 December 2020

inferred from PubMed ID database lookup

alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20373910

12 December 2020

inferred from PubMed ID database lookup

Total deposition of therapeutic particles during spontaneous and controlled inhalations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20373910

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1089/JAMP.2009.0793

1 reference

release_p4fx5qqja5gpjbcyogfmyxbu34

28 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p4fx5qqja5gpjbcyogfmyxbu34

24 November 2022

mapped directly with Wikidata item

PMCID

3116627

1 reference

28 July 2017

1 reference

PubMed ID

20373910